Related Experiment Video
Updated: Jun 4, 2025

Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice
Published on: June 2, 2022
Membrane Vesicles from Lactobacillus Acidophilus Reduce Intestinal Inflammation and Increase 5-HT in the Substantia
Khadijeh Sheikh1, Javad Arasteh1, Maryam Tajabadi Ebrahimi1
1Department of Biology, Central Tehran Branch, Islamic Azad University, Tehran, Iran.
Background:
This study aimed to investigate the role of membrane vesicles (MVs) from the probiotic Lactobacillus acidophilus in reducing intestinal inflammation and increasing 5-hydroxytryptamine (5-HT) and tyrosine hydroxylase (TH) in the substantia nigra in the 6-hydroxydopamine (6-OHDA) rat model of Parkinson's disease (PD).
Methods:
Twenty healthy male Wistar rats were randomly assigned to four groups (n = 5 per group), including a) control, b) 6-OHDA, c) 6-OHDA+MV, and d) sham groups. PD was induced by bilateral injection of 6-OHDA. Rats in the 6-OHDA+MV group received MV equivalent to 1 × 107 colony-forming units (CFU)/mL 3 d/wk by oral gavage for 4 wk. At the end of 4 wk, all rats were sacrificed; the brain and small intestine were removed for cellular and molecular analysis.
Results:
The induction of PD by 6-OHDA induced a remarkable decrease in beam-walking (p <0.0001). In addition, the expression of protein and genes (receptor) of 5-HT (r-5-HT1A) decreased, and that of protein and gene (receptor; GABBR1) of GABA increased in the PD group (p <0.05 compared with the healthy control group), while MV gavage of 6-OHDA-injected rats controlled these factors in the substantia nigra. In the intestinal tissue, the expression of TLR-4 and α-synuclein gene was significantly increased in the 6-OHDA group compared to the control group (p <0.0001).
Conclusion:
MVs might act as potential beneficial tools to reduce intestinal inflammation, control neurological damage associated with PD, and increase 5-HT neurotransmitters. It seems that MVs from L. acidophilus may have therapeutic potential in Parkinson's neurological disorder by controlling the gut-brain axis.
Insights
Membrane vesicles (MVs) from Lactobacillus acidophilus show potential in treating Parkinson's disease by reducing inflammation and improving neurotransmitter levels. This probiotic-derived therapy may offer a novel approach to managing neurological disorders via the gut-brain axis.
Area of Science:
- Neuroscience
- Microbiology
- Gastroenterology
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder with complex pathophysiology.
- Intestinal inflammation and altered neurotransmitter levels are implicated in PD progression.
- Probiotic-derived membrane vesicles (MVs) are emerging as potential therapeutic agents.
Purpose of the Study:
- To investigate the therapeutic potential of Lactobacillus acidophilus MVs in a rat model of PD.
- To assess the effect of MVs on intestinal inflammation and key neurotransmitters in the substantia nigra.
- To explore the role of MVs in modulating the gut-brain axis in PD.
Main Methods:
- A 6-hydroxydopamine (6-OHDA) rat model of PD was established.
- Rats received MVs from L. acidophilus via oral gavage.
- Brain and intestinal tissues were analyzed for molecular and cellular changes.
Main Results:
- 6-OHDA induced significant motor deficits and altered neurotransmitter expression (decreased 5-HT, increased GABA) in the substantia nigra.
- MVs mitigated these neurological changes in 6-OHDA-treated rats.
- Intestinal tissue showed increased TLR-4 and α-synuclein gene expression in the PD model, which was modulated by MV treatment.
Conclusions:
- L. acidophilus MVs demonstrate potential in reducing intestinal inflammation and neurological damage in PD.
- MVs may restore 5-HT neurotransmitter levels, suggesting a therapeutic role in Parkinson's disease.
- The findings highlight the therapeutic potential of MVs in modulating the gut-brain axis for PD management.
More Related Videos
06:39Author Spotlight: Accelerating Research on Bacterial Extracellular Vesicles Separation and Heterogeneity
Published on: September 1, 2023
07:31Brain Ventricular Microinjections of Lipopolysaccharide into Larval Zebrafish to Assess Neuroinflammation and Neurotoxicity
Published on: August 23, 2022
Related Concept Videos
Lysosomal Hydrolases
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...